Werewolf Therapeutics (HOWL) announced the appointment of Steven Bloom as Chief Business Officer. Bloom brings more than 35 years of experience in the life sciences industry leading teams in corporate development, commercial planning, corporate affairs, and strategic consulting.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOWL:
- Promising Investment in Werewolf Therapeutics: Strong Financials and Strategic Partnerships Drive Growth Prospects
- Unlocking Broader Therapeutic Potential: Andrew Fein’s Buy Rating on Werewolf Therapeutics
- Werewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with China
- Werewolf Therapeutics Reports 2024 Financial Results and Progress
- Werewolf Therapeutics reports Q4 EPS (46c), consensus (31c)